Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Feb 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to help prevent falls in people who have had total knee replacement surgery. The researchers want to see if a special treadmill training program, which helps people get used to quick changes in speed, can improve their balance and reduce the chances of falling during the first year after surgery. Participants will be asked to complete surveys about their health and fall history, undergo tests to assess their walking and balance, and wear an activity monitor. They will be divided into two groups: one group will receive information on fall prevention, while the other group will receive the same information and also participate in the treadmill training for two weeks.
To be eligible for this trial, participants should have severe knee arthritis that requires surgery soon, and they should be able to attend training sessions before their operation. However, those with certain health issues that could affect walking or balance, such as a history of strokes or balance disorders, will not be included. Throughout the year after their surgery, participants will be contacted every two weeks to check if they have experienced any falls. This study aims to find out if the treadmill training can really make a difference in preventing falls for those recovering from knee surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of endstage knee osteoarthritis requiring total knee arthroplasty (TKA). TKA scheduled within two months and able to schedule the required training visits prior to surgery.
- • Exclusion Criteria: Potential participants will be excluded if they have dizziness or self-reported medical conditions that would be expected to affect walking and balance. These specifically include history of stroke, multiple sclerosis, Parkinson's disease, and balance disorders including positional vertigo and Meniere's disease. Other exclusion criteria include plans to undergo a contralateral TKA within 12 months or history of other lower extremity joint replacement within 5 years. Finally, people who report idiopathic low back pain, history of heart disease, uncorrected vision impairment, or institutionalization will be excluded.
- • -
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Kharma Foucher, MD, PhD
Principal Investigator
University of Illinois Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials